← All Investors
TEVOGEN BIO HLDGS INC
Holders
0
Combined Value
$0
Combined Shares
0
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|
No tracked investors currently hold this security.
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Ken Griffin - Citadel Advisors | SOLD OUT | −$5.7K | ~$0.33 |
| Q1 2026 | Cliff Asness - AQR Capital | SOLD OUT | −$4.3K | ~$0.33 |
| Q4 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$5.7K | ~$0.33 |
| Q4 2025 | Cliff Asness - AQR Capital | SELL | −$3.2K | ~$0.33 |
| Q3 2025 | Cliff Asness - AQR Capital | SELL | −$4.1K | ~$0.79 |
| Q2 2025 | Cliff Asness - AQR Capital | BUY | +$2.1K | ~$1.25 |
| Q1 2025 | Israel Englander - Millennium Management | SOLD OUT | −$14K | ~$1.03 |
| Q1 2025 | Cliff Asness - AQR Capital | SELL | −$126 | ~$1.08 |
| Q4 2024 | Israel Englander - Millennium Management | NEW BUY | +$14K | ~$1.03 |
| Q4 2024 | Cliff Asness - AQR Capital | BUY | +$519 | ~$1.03 |
| Q3 2024 | Ken Griffin - Citadel Advisors | SOLD OUT | −$35K | ~$0.72 |
| Q3 2024 | Cliff Asness - AQR Capital | NEW BUY | +$9.6K | ~$0.37 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$35K | ~$0.72 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q4 2025 | 2 | 30,285 | +32.8% | $10K | $0.33 |
| Q3 2025 | 1 | 22,801 | −18.8% | $17K | $0.79 |
| Q2 2025 | 1 | 28,078 | +6.3% | $35K | $1.25 |
| Q1 2025 | 1 | 26,414 | −35.2% | $28K | $1.08 |
| Q4 2024 | 2 | 40,747 | +56.6% | $41K | $1.03 |
| Q3 2024 | 1 | 26,027 | −46.2% | $9.6K | $0.37 |
| Q2 2024 | 1 | 48,398 | — | $35K | $0.72 |